Asthma inhaler switch in 2024 could leave some patients scrambling
A popular asthma inhaler is being discontinued Jan. 1, fueling concerns that patients may have trouble getting insurance coverage for alternatives.
Dec 29, 2023
0
75
MeSH tree: C06.405.205.663
A popular asthma inhaler is being discontinued Jan. 1, fueling concerns that patients may have trouble getting insurance coverage for alternatives.
Dec 29, 2023
0
75
Biologics for the treatment of asthma were first introduced about 20 years ago. Since then, more and more people with asthma have found them to be an effective treatment in getting their symptoms under control.
Nov 9, 2023
0
36
Antireflux mucosal ablation (ARMA) cuts short-term gastroesophageal reflux disease (GERD) symptoms in two-thirds of patients undergoing the endoscopic treatment, according to a study published in the Journal of Gastroenterology ...
Nov 6, 2023
0
54
Reflux disease manifests as acid regurgitation and heartburn and is a known risk factor for esophageal cancer. However, a new study published in The BMJ by researchers at Karolinska Institutet now reports that the majority ...
Sep 13, 2023
0
61
A new study from Tulane University has identified a new treatment for a chronic immune system disease that can prevent children from eating.
Jul 31, 2023
0
125
Northwestern Medicine scientists have identified and characterized clinical outcomes and biomechanical patterns in eosinophilic esophagitis, according to a study published in the journal Gastroenterology. These findings will ...
Jul 5, 2023
0
34
Eliminating animal milk alone from the diet of adults with eosinophilic esophagitis (EoE) is as effective at treating the disease as eliminating animal milk plus five other common foods, a new clinical trial has found. For ...
Feb 27, 2023
0
326
In many ways, our intestines serve as the front gate between our bodies and the world around us. They help digest our food and absorb our medications. They send alarm signals when harmful bacteria, viruses, and allergens ...
Feb 6, 2023
0
57
Subcutaneous dupilumab administered weekly is associated with improved histologic outcomes and alleviation of symptoms among patients with eosinophilic esophagitis, according to a study published in the Dec. 22 issue of the ...
Dec 22, 2022
0
28
A weekly dose of dupilumab, a monoclonal antibody, led to a reduction of symptoms and tissue improvement in young adults and adolescents with eosinophilic esophagitis (EoE), according to a new study published in the New England ...
Dec 22, 2022
0
81